๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

15 recruiting trials

for EBV Infection After Allogenic HSCT

Evaluation of the Safety and Efficacy of LB-DTK-MV in Patients Diagnosed With Antiviral-Resistant CMV, BKV, or EBV Infection or Associated Diseases Following Anticancer Therapy or Allogeneic Hematopoietic Stem Cell Transplantation. NCT07670468Phase 1, Phase 21 site๐Ÿ“ Seoul LucasBio ยท Tests: LB-DTK-MV TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT. NCT04013802Phase 12 sites๐Ÿ“ Houston๐Ÿ“ Houston Baylor College of Medicine ยท Tests: HLA-matched VSTs Bridging Allogeneic Hematopoietic Stem Cell Transplantation or Not After CD19 CAR - T (S1904) Cell Therapy for r/r B-cell Acute Lymphoblastic Leukemia NCT06581081NA1 site๐Ÿ“ Beijing Peking University People's Hospital ยท Tests: Senl_B19 autologous CAR-T (S1904) treatment A Study to Assess Safety and Feasibility of Direct Infusions of Donor-derived Virus-specific T-cells in Recipients of Hematopoietic Stem Cell Transplantation With Post-transplant Viral Infections Using the Cytokine Capture Systemยฎ NCT02007356Phase 21 site๐Ÿ“ Basel University Hospital, Basel, Switzerland ยท Tests: IFN-ฮณ positive selected T-cells Letermovir Prophylaxis in Children With EBV-Positive T/NK-Cell Lymphoproliferative Disease and Refractory/Relapsed EBV-Associated Hemophagocytic Lymphohistiocytosis NCT07488728NA1 site๐Ÿ“ Beijing Beijing Children's Hospital ยท Tests: Letermovir Allo HSCT Using RIC and PTCy for Hematological Diseases NCT05805605Phase 21 site๐Ÿ“ Minneapolis Masonic Cancer Center, University of Minnesota ยท Tests: Peripheral Blood Stem Cell Transplant, Allopurinol 300 MG, Fludarabine, Cyclophosphamide, Bone Marrow Cell Transplant The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL NCT03509961Phase 224 sites๐Ÿ“ Birmingham๐Ÿ“ Phoenix๐Ÿ“ Duarte Pediatric Transplantation & Cellular Therapy Consortium ยท Tests: NGS-MRD, Myeloablative allogeneic HCT with a non-TBI conditioning regimen Prevention of Epstein-Barr Virus Reactivation With the ATG-based Haploidentical Protocol Combined With Rituximab in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation NCT07693881NA1 site๐Ÿ“ Guangzhou Nanfang Hospital, Southern Medical University ยท Tests: Rituximab (R) A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy NCT03394365Phase 371 sites๐Ÿ“ Duarte๐Ÿ“ La Jolla๐Ÿ“ Loma Linda Pierre Fabre Medicament ยท Tests: tabelecleucel Clinical Study of EBV-TCR-T Cells for EBV Infection After Allogenic HSCT NCT06119256Phase 11 site๐Ÿ“ Beijing Chinese PLA General Hospital ยท Tests: EBV-TCR-T cells Evaluation of Safety and Efficacy of Virus Specific T-Cell Administration in Pediatric Patients With Systemic Viral Infection Following Allogeneic Hematopoietic Stem Cell Transplantation. NCT07685457NA1 site๐Ÿ“ Seoul LucasBio ยท Tests: LB-DTK-MV Donor-Derived Viral Specific T-cells (VSTs) NCT02048332Phase 1, Phase 23 sites๐Ÿ“ Akron๐Ÿ“ Cincinnati๐Ÿ“ Cincinnati Children's Hospital Medical Center, Cincinnati ยท Tests: Viral specific VST Infusion Decitabine, Venetoclax and Blinatumomab for Maintenance Following HSCT in Patients With Ph-Negative B-ALL NCT06393985Phase 21 site๐Ÿ“ Suzhou The First Affiliated Hospital of Soochow University ยท Tests: Decitabine, venetoclax and blinatumomab Multivirus-specific T-cell Transfer Post SCT vs AdV, CMV and EBV Infections NCT04832607Phase 333 sites๐Ÿ“ Brussels๐Ÿ“ Brussels๐Ÿ“ Ghent Tobias Feuchtinger ยท Tests: Multivirus (CMV, EBV, AdV)-specific T cells Exploratory Study of EBV-TCR-T Cell Injection for EBV DNAemia After Allogeneic Hematopoietic Stem Cell Transplantation NCT07368634Phase 1, Phase 21 site๐Ÿ“ Beijing Daihong Liu ยท Tests: EBV-TCR-T Cell Injection
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy